Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

Front Endocrinol (Lausanne). 2018 Feb 22:9:50. doi: 10.3389/fendo.2018.00050. eCollection 2018.

Authors

Thomas Nyström¹, Irene Santos-Pardo¹, Fredric Hedberg¹, Johan Wardell¹, Nils Witt¹, Yang Cao^{2

3}, Leif Bojö⁴, Bo Nilsson⁴, Johan Jendle⁵

Affiliations

¹ Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
² Institution of Medical Sciences, Örebro University, Örebro, Sweden.
³ Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁴ Central Hospital, Karlstad, Sweden.
⁵ Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.

Abstract

[This corrects the article on p. 325 in vol. 8, PMID: 29184539.].

Keywords: liraglutide; longitudinal functional reserve index; subclinical heart failure; tissue Doppler echocardiography; type 2 diabetes.

Publication types

Published Erratum